40-2
40th Parliament,
2nd Session
(January 26, 2009 - December 30, 2009)
Select a different session
Meeting Detail
Bill S-232, An Act to amend the Patent Act (drugs for humanitarian purposes)
Witnesses
- Marilyn Coolen, Atlantic Representative - Leadership Team, National Advocacy Committee (Grandmothers to Grandmothers Campaign)
- Richard Dearden, Partner (Gowling, Lafleur, Henderson LLP)
- Ywe Looper, Manager Patents (Boehringer Ingelheim (Canada) Ltd)
- Paul Lucas, President and CEO (GlaxoSmithKline Canada)
- Gillian Sandeman, Ontario South-East Representative, Leadership Team, National Advocacy Committee (Grandmothers to Grandmothers Campaign)
- Kathleen Wallace-Deering, Co-Chair, National Advocacy Committee (Grandmothers to Grandmothers Campaign)
- Linda Watson, Prairies Rep - Leadership Team, National Advocacy Committee (Grandmothers to Grandmothers Campaign)
- Russell Williams, President (Canada's Research-Based Pharmaceuticals Companies)
Meeting with interpretation and transcription
*
Please note meeting changes.